Business Daily from THE HINDU group of publications
Wednesday, Aug 02, 2006
Business Daily from THE HINDU group of publications Wednesday, Aug 02, 2006 |
|
|
|
|
|
|
|
Corporate Results
-
Pharmaceuticals Dishman PAT up 97% at 18.5 cr Our Bureau
Ahmedabad , Aug. 1 Dishman Pharmaceuticals & Chemical Limited, Ahmedabad, has recorded a sharp increase in net sales, profit before tax (PBT) and profit after tax (PAT) in the first quarter of the fiscal year 2006-07 ending June 2006.
Net sales up 35%
According to the un-audited financial result for the quarter ended June 30, 2006, approved by the Board of Directors at their meeting on Monday, the consolidated net sales for the first quarter of the current year was Rs 82.24 crore, as against the first quarter of the previous year of Rs 61.04 crore, an increase of 35 per cent. The consolidated PBT and PAT were Rs 19.38 crore and Rs 18.56 crore respectively against Rs 10.02 crore and Rs 9.41 crore. This was an increase of 93 per cent and 97 per cent respectively, the company said in a release here.
Stand-alone basis
The company's performance has been positive even on a stand-alone basis. The total revenue from net sales/income from operations was Rs 57.98 crore (Rs 41.37 crore), an increase of 40 per cent. Similarly, Profit Before Interest Depreciation and Tax (PBIDT) for the current quarter stood at Rs 18.81 crore against a figure of Rs 11.99 crore, which is a rise of 57 per cent. PBT for the current quarter stood at Rs 15.33 crore (Rs 8.52 crore), an increase of about 80 per cent. After providing for tax, PAT is Rs 14.51 crore (Rs 8.15 crore), an increase of 78 per cent.
More Stories on : Pharmaceuticals
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2006, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|